Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic antihypertensive medication and incident open-angle glaucoma.

Rogier P H M Müskens1, Simone de Voogd, Roger C W Wolfs

  • 1Department of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Ophthalmology
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction.

Psychoneuroendocrinology·2010
Same author

Common genetic determinants of vitamin D insufficiency: a genome-wide association study.

Lancet (London, England)·2010
Same author

Heart failure and incident late-life depression.

Journal of the American Geriatrics Society·2010
Same author

Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study.

The Journal of clinical endocrinology and metabolism·2010
Same author

Predicting survival and morbidity-free survival to very old age.

Age (Dordrecht, Netherlands)·2010
Same author

Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index.

Annals of the rheumatic diseases·2010
Same journal

Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin.

Ophthalmology·2026
Same journal

The Answer Is Blowing in the Wind: Uncovering Hidden Glaucoma Risk Factors.

Ophthalmology·2026
Same journal

Nonsteroidal Anti-inflammatory Drug Use Reduces the Risk of Age-Related Macular Degeneration in Electronic Health Record Analysis: Signal or Solution?

Ophthalmology·2026
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
Same journal

Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

Ophthalmology·2026
Same journal

Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma.

Ophthalmology·2026
See all related articles

Systemic antihypertensive medication, specifically calcium channel antagonists, may increase the risk of developing open-angle glaucoma. Further research is needed to confirm this association and its implications for glaucoma treatment.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Epidemiology

Background:

  • Open-angle glaucoma is a leading cause of irreversible blindness worldwide.
  • Systemic antihypertensive medications are widely prescribed for cardiovascular conditions.
  • The potential ocular side effects of these medications are not fully understood.

Purpose of the Study:

  • To investigate the association between the use of systemic antihypertensive medications and the incidence of open-angle glaucoma.
  • To identify specific classes of antihypertensive drugs that may influence glaucoma risk.

Main Methods:

  • A prospective, population-based cohort study involving 3842 participants from the Rotterdam Study.
  • Antihypertensive medication use was recorded over an average follow-up of 6.5 years.

Related Experiment Videos

  • Multivariate logistic regression models were used to assess associations, adjusting for key confounding factors.

    • Main Results:

    • Eighty-seven incident cases of open-angle glaucoma were diagnosed during follow-up.
    • Calcium channel antagonists were associated with a statistically significant 1.8-fold increased risk of incident open-angle glaucoma.
    • Beta-blockers showed a trend towards risk reduction, but this was not statistically significant; other antihypertensives showed no significant association.

    Conclusions:

    • The use of calcium channel antagonists may be associated with an increased risk of developing open-angle glaucoma.
    • These findings warrant further investigation and confirmation through additional studies.
    • Current evidence does not support the use of calcium channel antagonists for treating normal-tension glaucoma.